Keystone Investors PTE Ltd. boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 289.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 24,355 shares of the semiconductor company’s stock after buying an additional 18,096 shares during the period. Synopsys makes up approximately 1.4% of Keystone Investors PTE Ltd.’s holdings, making the stock its 19th largest holding. Keystone Investors PTE Ltd.’s holdings in Synopsys were worth $12,017,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV raised its stake in shares of Synopsys by 37.3% in the third quarter. Creative Financial Designs Inc. ADV now owns 162 shares of the semiconductor company’s stock valued at $80,000 after acquiring an additional 44 shares during the period. Allianz SE grew its holdings in Synopsys by 38.4% during the 3rd quarter. Allianz SE now owns 8,260 shares of the semiconductor company’s stock valued at $4,075,000 after purchasing an additional 2,291 shares during the last quarter. Generali Investments Management Co LLC raised its position in Synopsys by 275.7% in the 3rd quarter. Generali Investments Management Co LLC now owns 3,163 shares of the semiconductor company’s stock worth $1,561,000 after purchasing an additional 2,321 shares during the period. TIAA Trust National Association lifted its stake in Synopsys by 404.4% in the third quarter. TIAA Trust National Association now owns 41,702 shares of the semiconductor company’s stock worth $20,575,000 after purchasing an additional 33,435 shares during the last quarter. Finally, Telligent Fund LP boosted its position in shares of Synopsys by 30.0% during the third quarter. Telligent Fund LP now owns 6,500 shares of the semiconductor company’s stock valued at $3,207,000 after buying an additional 1,500 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock valued at $1,945,036 over the last quarter. Insiders own 0.62% of the company’s stock.
More Synopsys News
- Positive Sentiment: Q1 beat and AI-driven revenue surge — Synopsys reported Q1 revenue up ~65% and an EPS beat, driven by EDA demand and the Ansys deal; the results validate AI-led chip‑design tailwinds. Synopsys Q1 Earnings
- Positive Sentiment: Ansys integration expands long‑term TAM — Management and analysts highlight that combining EDA with Ansys simulation opens full‑system design markets (servers, autonomous systems), which could materially enlarge revenue opportunities over the medium term. Can AI Push in EDA & Ansys Integration?
- Positive Sentiment: Capital return and trader interest — Board approved a $2B buyback and there was high call‑option volume / large option trades, signaling bullish positioning by some traders. Those actions provide buy‑side support. Why Is Synopsys Stock Falling? Call Options Volume
- Neutral Sentiment: Analyst consensus still skewed positive, but stock has lagged peers — Wall Street average rating remains around “Buy” even as SNPS underperformed some tech peers over the past year, leaving room for divergence between sentiment and price action. How Is Synopsys’ Stock Performance Compared?
- Negative Sentiment: Guidance and China/export risks — Management flagged a muted near‑term quarter and a Q2 revenue guide that disappointed some investors; Reuters notes export restrictions to China as a headwind to visibility. Reuters: Muted Quarter
- Negative Sentiment: Integration costs, GAAP loss and IP weakness — Analysts and social commentary point to near‑term profitability pressure from Ansys deal costs, one‑time charges and workforce reductions, plus continued softness in the Design IP segment. QuiverQuant: Integration & IP Issues
- Negative Sentiment: Analyst price‑target trims — Several firms trimmed targets or moved to neutral/equal‑weight after the report (Piper Sandler, Wells Fargo, Rosenblatt adjustments), which can depress sentiment even if ratings remain constructive. Benzinga: Price Target Changes
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $414.00 on Friday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a market cap of $79.31 billion, a PE ratio of 64.29, a P/E/G ratio of 3.55 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The business has a 50-day simple moving average of $471.21 and a two-hundred day simple moving average of $477.25.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. The firm had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 7.49%. Synopsys’s revenue was up 65.6% on a year-over-year basis. During the same period last year, the firm posted $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on SNPS shares. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. KeyCorp upped their price target on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Piper Sandler dropped their target price on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a research note on Thursday. Finally, HSBC lowered Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target for the company. in a report on Friday, February 20th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Synopsys has an average rating of “Hold” and an average target price of $531.00.
View Our Latest Stock Report on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- The Biggest IPO Ever… Open to Everyday Folks
- Read this or regret it forever
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
